Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 366 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page


    Advanced search

    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  

    The Case

 Article Access Statistics
    PDF Downloaded246    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


CASE REPORT Table of Contents   
Year : 2006  |  Volume : 48  |  Issue : 3  |  Page : 196-197
Clozapine in pregnancy

Department of Psychiatry, PGIMS, Rohtak, India

Click here for correspondence address and email


This report describes the case of a woman with treatment-resistant schizophrenia who became pregnant while being treated successfully with clozapine. Possible risks associated with continuation of clozapine during pregnancy are discussed.

Keywords: Clozapine, pregnancy

How to cite this article:
Sethi S. Clozapine in pregnancy. Indian J Psychiatry 2006;48:196-7

How to cite this URL:
Sethi S. Clozapine in pregnancy. Indian J Psychiatry [serial online] 2006 [cited 2020 May 29];48:196-7. Available from:

   Introduction Top

Increasing use of clozapine in the treatment of psychotic illness has associated caveats. One of these being increased chances of pregnancy both desired and unwanted in woman taking clozapine. Sufficient data are not available to psychiatrists to guide the management of such cases. The following case adds to the existing data on the use of clozapine during pregnancy.

   The Case Top

Ms S, a 20-year-old unmarried woman from middle socio­economic status, presented with a history of 2 years' duration suggestive of schizophrenia according to the DSM-IV guidelines. She had been treated with various typical and atypical antipsychotics. She showed no improvement but experienced side-effects. So treatment with clozapine was considered. Under regular leucocyte monitoring, the dose of clozapine was gradually increased to a maximum of 250 mg/ day. She showed remarkable improvement and got married in the next 6 months. Despite repeated advice to practice contraception, Ms S disclosed about being pregnant at the end of the first trimester. She and her husband were counselled on the possible harm to the foetus by clozapine, but they decided to continue with the pregnancy as well as with the treatment at the same dose fearing that she might relapse with dose reduction. Besides regular antenatal check-up, blood sugar and leucocyte counts were monitored regularly. She delivered a healthy female child without any complications. She was advised not to breastfeed. The child has been followed up for 2 years and has shown no developmental delays. The patient is also maintaining well.

   Discussion Top

Data regarding the potential teratogenicity of clozapine are not unanimous. There are reports of no congenital abnor­malities with clozapine in animals and human beings.[1] In contrast, Dev and Krupp reviewed the literature and reported congenital malformations in 10 children and perinatal syndromes in 61 children exposed to clozapine during pregnancy.[2] Another report described intrauterine foetal death in a woman taking clozapine but it is not clear whether it was clozapine only or a combination of other factors which contributed to this outcome.[3] Increased glucose intolerance during pregnancy,[4] precipitation of gestational diabetes with shoulder dystocia[5],[6] have been reported in patients taking clozapine.

However, in our patient clozapine was continued at the same dose throughout the gestational period with no hyperglycaelmia or any complication during labour and delivery. The child also showed no congenital anomaly. Breastfeeding was not advised considering the high concentration of clozapine in breast milk and exposing the child further to clozapine.[7]

Since the introduction of atypical antipsychotics particularly clozapine, increasing number of patients with treatment-resistant schizophrenia are benefiting in terms of remission and better social functioning. Unlike typical antipsychotics, clozapine does not cause hyperprolactinaemia, thus increasing the chances of a woman taking clozapine to conceive. Though the patient described here had an uneventful pregnancy while on clozapine, it needs to be emphasized that like other psychotropics clozapine should be used with caution during pregnancy. This is more so with clozapine as there is insufficient knowledge regarding clozapine-induced agranulo­cytosis in foetus/neonate.

   References Top

1.Ernst CL, Goldberg JF. The reproductive safety profile of mood stabilizers, atypical antipsychotics and broad-spectrum psychotropics. J Clin Psychiatry 2002;63:42-55.  Back to cited text no. 1  [PUBMED]  
2.Dev V, Krupp P. The side effects and safety of clozapine. Rev Contemp Pharmacother 1995;6:197-208.  Back to cited text no. 2    
3.Mendhekar DN, Sharma JB, Srivastava PK, et al. Clozapine and pregnancy. J Clin Psychiatry 2003;64:850.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Popli AA, Konicki PF, Jurjus GJ, et al. Clozapine and associated diabetes mellitus. J Clin Psychiatry 1997;58: 108-11.  Back to cited text no. 4    
5.Waldman MD, Safferman A. Pregnancy and clozapine [letter]. Am J Psychiatry 1993;150:168-9.  Back to cited text no. 5    
6.Dickson RA, Hogg L. Pregnancy of a patient treated with clozapine. Psychiatr Serv 1998;49:1081-3.  Back to cited text no. 6  [PUBMED]  [FULLTEXT]
7.Barnas C, Bergant A, Hummer M, et al. Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast mild [letter]. Am J Psychiatry 1994;151:945.  Back to cited text no. 7  [PUBMED]  

Correspondence Address:
Sujata Sethi
122/8, Shivaji Colony, Rohtak 124001, Haryana
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0019-5545.31586

Rights and Permissions

This article has been cited by
1 Bipolar disorder differences between genders: special considerations for women
Margarita Saenz, Ana González-Pinto, Patricia Vega, Sara Barbeito, Sonia Ruiz de Azúa, Mónica Martínez-Cengotitabengoa, Itxaso González-Ortega
Women s Health. 2011; 7(6): 663
[VIEW] | [DOI]